Quantitation of Cellular Components in Cryptococcus neoformans for System Biology Analysis

Methods in Molecular Biology

Volumn 734, Issue , 2011, Pages 317-333

  Singh, Arpita ^b   Qureshi, Asfia ^b   Del Poeta, Maurizio ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE

Author keywords

Biochemistry; Cryptococcus neoformans; DNA; Fungal infection; Genetic; Lipids; Molecular biology; Protein; RNA; Sphingolipid

Indexed keywords

FUNGAL DNA; FUNGAL PROTEIN; FUNGAL RNA; LIPID;

ARTICLE; BIOLISTIC TRANSFORMATION; CHEMISTRY; CRYPTOCOCCUS NEOFORMANS; CYTOLOGY; ENZYME ASSAY; HUMAN; HYDROLYSIS; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; SOUTHERN BLOTTING; SYSTEMS BIOLOGY; THIN LAYER CHROMATOGRAPHY;

BIOLISTICS; BLOTTING, SOUTHERN; CHROMATOGRAPHY, THIN LAYER; CRYPTOCOCCUS NEOFORMANS; DNA, FUNGAL; ENZYME ASSAYS; FUNGAL PROTEINS; HUMANS; HYDROLYSIS; LIPIDS; MASS SPECTROMETRY; RNA, FUNGAL; SYSTEMS BIOLOGY;

EID: 79960136822     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-086-7_16     Document Type: Chapter

References (24)

1. Harrison, T. S. (2009) The burden of HIVassociated cryptococcal disease. AIDS 23, 531–2.
2. Park, B. J., Wannemuehler, K. A., Marston, B. J., Govender, N., Pappas, P. G., and Chiller, T. M. (2009) Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23, 525–30.
3. Hajjeh, R. A., Conn, L. A., Stephens, D. S., Baughman, W., Hamill, R., Graviss, E., Pappas, P. G., Thomas, C., Reingold, A., Rothrock, G., Hutwagner, L. C., Schuchat, A., Brandt, M. E., and Pinner, R. W. (1999) Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group. J Infect Dis 179, 449–54.
4. Kaplan, M. H., Rosen, P. P., and Armstrong, D. (1977) Cryptococcosis in a cancer hospital: clinical and pathological correlates in forty-six patients. Cancer 39, 2265–74.
5. White, M., Cirrincione, C., Blevins, A., and Armstrong, D. (1992) Cryptococcal meningitis: outcome in patients with AIDS and patients with neoplastic disease. J Infect Dis 165, 960–3.
6. Kohno, S., Varma, A., Kwon-Chung, K. J., and Hara, K. (1994) Epidemiology studies of clinical isolates of Cryptococcus neoformans of Japan by restriction fragment length polymorphism. Kansenshogaku Zasshi 68, 1512–7.
7. Shaariah, W., Morad, Z., and Suleiman, A. B. (1992) Cryptococcosis in renal transplant recipients. Transplant Proc 24, 1898–9.
8. Husain, S., Wagener, M. M., and Singh, N. (2001) Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis 7, 375–81.
9. Fraser, J. A., Giles, S. S., Wenink, E. C., Geunes-Boyer, S. G., Wright, J. R., Diezmann, S., Allen, A., Stajich, J. E., Dietrich, F. S., Perfect, J. R., and Heitman, J. (2005) Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature 437, 1360–4.
10. Seaton, R. A., Verma, N., Naraqi, S., Wembri, J. P., and Warrell, D. A. (1997) Visual loss in immunocompetent patients with Cryptococcus neoformans var. gattii meningitis. Trans R Soc Trop Med Hyg 91, 44–9.
11. Seaton, R. A., Naraqi, S., Wembri, J. P., and Warrell, D. A. (1996) Predictors of outcome in Cryptococcus neoformans var. gattii meningitis. Qjm 89, 423–8.
12. Findley, K., Rodriguez-Carres, M., Metin, B., Kroiss, J., Fonseca, A., Vilgalys, R., and Heitman, J. (2009) Phylogeny and phenotypic characterization of pathogenic Cryptococcus species and closely related saprobic taxa in the Tremellales. Eukaryot Cell 8, 353–61.
13. Perfect, J. R. (2005) Cryptococcus neoformans: a sugar-coated killer with designer genes. FEMS Immunol Med Microbiol 45, 395–404.
14. Casadevall, A., and Perfect, J. R. (1998) Cryptococcus neoformans, ASM Press, Washington, DC, 381–405.
15. Hull, C. M., and Heitman, J. (2002) Genetics of Cryptococcus neoformans. Annu Rev Genet 36, 557–615.
16. Toffaletti, D. L., Rude, T. H., Johnston, S. A., Durack, D. T., and Perfect, J. R. (1993) Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J. Bacteriol. 175, 1405–11.
17. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular cloning: a laboratory manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
18. Baker, L. G., Specht, C. A., Donlin, M. J., and Lodge, J. K. (2007) Chitosan, the deacetylated form of chitin, is necessary for cell wall integrity in Cryptococcus neoformans. Eukaryot Cell 6, 855–67.
19. Mandala, S. M., Thornton, R. A., Frommer, B. R., and et al. (1995) The discovery of australifungin, a novel inhibitor of sphinganine N-acyltransferase from Sporormiella australis. Producing organism, fermentation, isolation, and biological activity. J. Antibiot. (Tokyo) 48, 349–56.
20. Luberto, C., Toffaletti, D. L., Wills, E. A., Tucker, S. C., Casadevall, A., Perfect, J. R., Hannun, Y. A., and Del Poeta, M. (2001) Roles for inositol-phosphoryl ceramide synthase 1 (IPC1) in pathogenesis of C. neoformans. Genes Dev. 15,201–12.
21. Fischl, A. S., Liu, Y., Browdy, A., and Cremesti, A. E. (2000) Inositolphosphoryl ceramide synthase from yeast. Methods Enzymol. 311, 123–30.
22. Bielawski, J., Pierce, J. S., Snider, J., Rembiesa, B., Szulc, Z. M., and Bielawska, A. (2009) Comprehensive quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Methods Mol Biol 579, 443–67.
23. Bielawski, J., Szulc, Z. M., Hannun, Y. A., and Bielawska, A. (2006) Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatographytandem mass spectrometry. Methods 39, 82–91.
24. Hanson, B. A., and Lester, R. L. (1980) The extraction of inositol-containing phospholipids and phosphatidylcholine from Saccharomyces cerevisiae and Neurospora crassa. J Lipid Res 21, 309–15.